Aligos Therapeutics, Inc. (ALGS)
Nasdaq: ALGS · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2020
Who runs Aligos Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Blatt Lawrence
President and CEO. First filing Oct 2020, latest Mar 11, 2026, 0 filings in all.
Officers reporting now
4
of 10 people with a filing in the last fifteen months
Directors reporting now
6
18 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Blatt Lawrence | President and CEO | Oct 2020 | Mar 11, 2026 | none |
| Symons Julian A. | Executive Vice President, Chief Scientific Officer | Oct 2020 | Mar 11, 2026 | none |
| Calhoun Lesley Ann | Chief Operating Officer and Chief Financial Officer | Oct 2020 | Mar 11, 2026 | none |
| Aneja Nikhil | Principal Accounting Officer | Feb 2026 | Mar 11, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chavez Margarita | director | Aug 2024 | Jun 29, 2026 | none |
| Hirth Peter | director | Oct 2020 | Jun 29, 2026 | none |
| Martell Bridget A | director | Nov 2021 | Jun 29, 2026 | none |
| Nuechterlein Carole | director | Oct 2020 | Jun 29, 2026 | none |
| Preston Heather | director | Aug 2024 | Jun 29, 2026 | none |
| Scopa James Paul | director | Apr 2021 | Jun 29, 2026 | none |
Earlier names on the record17, newest filing first
Achneck Hardean · officer · last filing Oct 2024Mcclure Matthew W. · officer · last filing Mar 2024Nielsen Jack · director · last filing Feb 2024Roche Finance Ltd · 10% owner · last filing Nov 2023Roche Holding Ltd · 10% owner · last filing Nov 2023Quan Lucinda Y. · officer · last filing Sep 2023Beigelman Leonid · officer · last filing Mar 2023Woiwode Thomas · director · last filing Jun 2022Novo Holdings A/s · 10% owner · last filing Oct 2020Wellington Biomedical Innovation Master Investors (Cayman) I L.P. · 10% owner · last filing Oct 2020Versant Vantage I, L.P. · 10% owner · last filing Oct 2020Versant Venture Capital Vi, L.P. · 10% owner · last filing Oct 2020Vivo Capital Fund Viii, L.P. · 10% owner · last filing Oct 2020Vivo Capital Surplus Fund Viii, L.P. · 10% owner · last filing Oct 2020Vivo Capital Viii, LLC · 10% owner · last filing Oct 2020Glaub Kathleen Sereda · director · last filing Oct 2020Moldt Peter · director · last filing Oct 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.